论文部分内容阅读
目的:对脑梗死患者高血压临床治疗方案进行探讨。方法:随机选择该院2014年2月至2016年1月接收、已确诊的脑梗死患者共46例,均出现高血压症状,随机分成2组:分析组:有患者23例,于组内推行依达拉奉方案治疗;对照组:有患者23例,于组内推行常规疗法,观察入选患者疗效。结果:分析组神经功能ESS评定分数以及日常生活能力(ADL)评定分数等指标均优于对照组(P<0.05)。结论:在脑梗死患者治疗中展开依达拉奉方案具有可行性,建议推广。
Objective: To investigate the clinical treatment of hypertension in patients with cerebral infarction. Methods: A total of 46 patients with confirmed cerebral infarction who were admitted to our hospital from February 2014 to January 2016 were selected randomly and divided into 2 groups randomly. Analysis group: There were 23 patients who were in the group Edaravone treatment; control group: 23 patients, the implementation of conventional therapy in the group to observe the efficacy of selected patients. Results: The indexes of ESS assessment score and ADL score in the analysis group were better than those in the control group (P <0.05). Conclusion: It is feasible and feasible to develop edaravone in the treatment of patients with cerebral infarction.